“After COVID” is hard to imagine, as is just how long it will take us—globally, nationally, regionally— to get there. The term “new normal” has already become old and overused, but what does it really mean? The truth is that we can’t provide any concrete answers to this complex question, but we can examine empirical patterns that are already observable.
A panel including Dr. Michael Osterholm, White House advisor, epidemiologist and Director of the Center for Infectious Disease Research and Policy at the University of Minnesota; Rachel Silverman, policy fellow Center for Global Development, and Dr. Amesh Adalja Johns Hopkins, Center for Global Health and Johns Hopkins Center for Health Security predict what might change fundamentally and what lessons about preparedness we will have learned.
Politics in the Era of Global Pandemic— 2.0, is produced by Ford Hall Forum at Suffolk University, the Political Science & Legal Studies department at Suffolk University, and the GBH Forum Network. Guest speakers examine the issues at play in year two of the COVID-19 pandemic, from global infection rates to the havoc on the economy, our politics, and our trust in our governments.
“The Case for Investing in Public Health ”, by the European Health Organization, 2020.
“About Variants ” CDC, 08/06/202.
“‘Act now’ on global vaccines to stop more-dangerous variants, experts warn Biden ” By Dan Diamond and Yasmeen Abutaleb, The Washington Post, 08/10/2021.
BIO: Rachel Silverman
Rachel Silverman is a policy fellow at the Center for Global Development, where she leads policy-oriented research on global health financing and incentive structures. Silverman’s current research focuses on the practical application of results-based financing; global health transitions; efficient global health procurement; innovation models for global health; priority-setting for UHC; alignment and impact in international funding for family planning; and strategies to strengthen evidence and accountability. Before joining CGD in 2011 she worked with the National Democratic Institute to support democracy and governance strengthening programs in Kosovo. She holds a master’s of philosophy with distinction in public health from the University of Cambridge, which she attended as a Gates Cambridge Scholar. She also holds a BA with distinction in international relations and economics from Stanford University.
BIO: Eugene Daniels
Eugene Daniels is a Playbook author and White House correspondent at POLITICO, with a focus on Vice President Kamala Harris, First Lady Dr. Jill Biden, the Second Gentleman and emerging power players in Washington.
BIO: Michael Osterholm
Dr. Osterholm has been an international leader on the critical concern regarding our preparedness for an influenza pandemic. His recent invited papers in the journals Foreign Affairs, the New England Journal of Medicine, and Nature detail the threat of an influenza pandemic and steps we must take to better prepare for that event. Dr. Osterholm has also been an international leader on the growing concern regarding the use of biological agents as catastrophic weapons targeting civilian populations. In that role, he served as a personal advisor to the late King Hussein of Jordan. Dr. Osterholm is director of the Center for Infectious Disease Research and Policy (CIDRAP), director of the NIH-supported Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS) within CIDRAP, a professor in the Division of Environmental Health Sciences, and an adjunct professor in the Medical School, University of Minnesota. He is also a member of the Institute of Medicine (IOM) of the National Academy of Sciences. Dr. Osterholm provides a comprehensive and pointed review of America’s current state of preparedness for a bioterrorism attack in his New York Times best-selling book, Living Terrors: What America Needs to Know to Survive the Coming Bioterrorist Catastrophe. The author of more than 300 papers and abstracts, including 20 book chapters, Dr. Osterholm is a frequently invited guest lecturer on the topic of epidemiology of infectious diseases. He serves on the editorial boards of five journals, including Infection Control and Hospital Epidemiology and Microbial Drug Resistance: Mechanisms, Epidemiology and Disease, and he is a reviewer for 24 additional journals, including the New England Journal of Medicine, the Journal of the American Medical Association, and Science.
BIO: Amesh Adalja
Dr. Adalja is a Senior Scholar at the Johns Hopkins University Center for Health Security. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity.